MedPath

The comparison glycemic control in two group patient treated with insulin alone and insulin plus sulfunyl urea

Phase 2
Conditions
Type II Diabetes.
Type II Diabetes
Registration Number
IRCT201204229536N1
Lead Sponsor
Vice chancellor for research, Qazvin University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
45
Inclusion Criteria

history of diabetes mellitus; secondary failure ( HbA1C>7.5 FBS>140 ) and treating with sulfonylurea.
Exclusion criteria: sever heart failure; renal failure ( cr>2.5); artherial failure; take corticosteroide; Diabetic ketoacidosis; liver failure; hypotension and critical illness.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood glucose. Timepoint: 4 times a day. Method of measurement: Glucometer.;Weight gain. Timepoint: 3 months after intervention. Method of measurement: Digital scale.;Hypoglycemic event. Timepoint: 3 months after intervention. Method of measurement: Glucometer.
Secondary Outcome Measures
NameTimeMethod
Dosage of the insulin. Timepoint: 4 times a day. Method of measurement: With insulin syringes.
© Copyright 2025. All Rights Reserved by MedPath